PPROM Registry (Preterm Premature Rupture of Membranes)
Recruiting
Observational Study
Fetal Membranes, Premature Rupture
Preterm Premature Rupture of the Membranes
Oligohydramnios
Premature Birth
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 14 – 55
- Sex
- Female
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- American Alliance for pProm Support · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.
Trial Locations
Loading…
Loading trial locations…
| Facility |
City |
State |
Country |
Status |
Eligibility Criteria
Inclusion Criteria:
* Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy
Exclusion Criteria:
* Those without a clinical diagnosis or confirmation of PPROM in pregnancy
* Diagnosis of PROM beyond 37 weeks of pregnancy
Inclusion Criteria:
* Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy
Exclusion Criteria:
* Those without a clinical diagnosis or confirmation of PPROM in pregnancy
* Diagnosis of PROM beyond 37 weeks of pregnancy